{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:39:45Z","timestamp":1787859585972,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12350-022-02945-2","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T17:12:36Z","timestamp":1647364356000},"page":"1952-1955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transmural perfusion: A new direction for myocardial blood flow"],"prefix":"10.1016","volume":"29","author":[{"given":"Dominik C.","family":"Benz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp A.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Dorbala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-022-02945-2_bib1","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-022-02945-2_bib2","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s12350-018-1298-4","article-title":"Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?","volume":"26","author":"Bravo","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-02945-2_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-022-02945-2_bib4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","article-title":"Intramural (\"small vessel\") coronary artery disease in hypertrophic cardiomyopathy","volume":"8","author":"Maron","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-02945-2_bib5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jacc.2011.05.018","article-title":"Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations","volume":"58","author":"Olivotto","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-02945-2_bib6","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","article-title":"Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric magnetic resonance imaging","volume":"115","author":"Petersen","year":"2007","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-02945-2_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCIMAGING.112.000110","article-title":"Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy","volume":"6","author":"Bravo","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-02945-2_bib8","doi-asserted-by":"crossref","first-page":"H986","DOI":"10.1152\/ajpheart.00233.2007","article-title":"Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy","volume":"294","author":"Knaapen","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1007\/s12350-022-02945-2_bib9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.75.6.1130","article-title":"Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy","volume":"75","author":"Tanaka","year":"1987","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-02945-2_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0735-1097(91)90869-B","article-title":"Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography","volume":"17","author":"Camici","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-02945-2_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015294","article-title":"Apical hypertrophic cardiomyopathy: The variant less known","volume":"9","author":"Hughes","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1007\/s12350-022-02945-2_bib12","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1111\/chd.12242","article-title":"Genotype-phenotype correlations in apical variant hypertrophic cardiomyopathy","volume":"10","author":"Towe","year":"2015","journal-title":"Congenit Heart Dis"},{"key":"10.1007\/s12350-022-02945-2_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1536\/jhj.44.505","article-title":"Cardiac muscle cell disorganization in apical hypertrophic cardiomyopathy: A cardiac biopsy study","volume":"44","author":"Morimoto","year":"2003","journal-title":"Jpn Heart J"},{"key":"10.1007\/s12350-022-02945-2_bib14","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-02945-2_bib15","doi-asserted-by":"crossref","unstructured":"Calabretta R, Kokomani A, Fumagalli C, Olivotto I, Camici PG, Hacker M, Sciagr\u00e0 R. Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy. J Nucl Cardiol 2022. https:\/\/doi.org\/10.1007\/s12350-022-02911-y. Erratum in: J Nucl Cardiol 2022. https:\/\/doi.org\/10.1007\/s12350-022-02926-5.","DOI":"10.1007\/s12350-022-02926-5"},{"key":"10.1007\/s12350-022-02945-2_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijcard.2017.09.206","article-title":"Ineffective and prolonged apical contraction is associated with chest pain and ischaemia in apical hypertrophic cardiomyopathy","volume":"251","author":"Stephenson","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-022-02945-2_bib17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.RES.49.3.742","article-title":"Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in dogs with left ventricular hypertrophy","volume":"49","author":"Bache","year":"1981","journal-title":"Circ Res"},{"key":"10.1007\/s12350-022-02945-2_bib18","article-title":"Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy","volume":"26","author":"Magnusson","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1007\/s12350-022-02945-2_bib19","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00259-015-3101-y","article-title":"Validation of pixel-wise parametric mapping of myocardial blood flow with 13NH3 PET in patients with hypertrophic cardiomyopathy","volume":"42","author":"Sciagr\u00e0","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-022-02945-2_bib20","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.amjcard.2016.08.085","article-title":"Effect of diffuse subendocardial hypoperfusion on left ventricular cavity size by 13N-ammonia perfusion PET in patients with hypertrophic cardiomyopathy","volume":"118","author":"Yal\u00e7in","year":"2016","journal-title":"Am J Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-02945-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-022-02945-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123004907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123004907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-02945-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:11:30Z","timestamp":1761027090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123004907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1071358123004907"],"URL":"https:\/\/doi.org\/10.1007\/s12350-022-02945-2","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transmural perfusion: A new direction for myocardial blood flow","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-022-02945-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}